Hanmi Pharmaceutical(President&CEO, Lee Gwan-sun) has a plan to build the Global Smart Plant with annual capacity of 10 billion pills to expand export finished products and commission business.
On April 1st, Hanmi announced that it will invest 120 billion KRW in establishing additional Global Smart Plant with a total ground area of 36,523㎡ and a eight-floor building and a basement, which is scheduled to be built within the Paltan complex in July, 2016.
The Global Plant, which will be carried out after securing additional site within the Paltan complex, is going to meet the advanced system satisfying cGMP, the production rule of medicines in developed countries including the U.S.
Once building the plant is complete, the Paltan complex of Hanmi will become Korea’s largest pharmaceutical production site with annual capacity of 12 billion pills.
In particular, the Global Smart Plant is designed with split valves preventing cross-contamination by introducing latest continuous processing equipment where blending, granulation and hot-driven process are done one-stop.
Hanmi(www.hanmipharm.com) will expand commission business targeting global pharmaceutical companies as well as producing annually increasing export goods of finished medicines in the plant.
“The Global Smart Plant will be aimed to produce automatically from production to logistics,” said Woo Jong-soo, Hanmi’s V.P., “We will put efforts to build the new plant with a conviction that it will upgrade Korea’s paradigm of pharmaceutical production.”
By Lee Kyung-ho